Dr William Boothe - Restorative Therapies, Inc., Receives FDA Clearance for Enhancement to RT300-S Electrical Stimulation Cycle

From: paul.kholer paul.kholer <paul.kholer_at_gmail.com>
Date: Fri, 24 Aug 2007 17:44:08 +0300

Restorative Therapies, Inc., advances its New Era in Treatment for
Neurological Injury and Paralysis.

 Restorative Therapies, Inc., a designer of medical devices, today announced
FDA clearance of a BlueTooth Pulse Oximeter for its successful medical
device, the RT300-S , a functional electrical stimulation (FES) motorized
cycle ergometer.

 In the treatment of neurological damage, FES is used to evoke physical
activity and exercise not otherwise possible for individuals with paralysis.
The RT300-S delivers electrical currents to activate the leg muscles
important for walking including the quadriceps, hamstring and gluteal
muscles, enabling paralyzed legs to move through a regular patterned
physical activity.

 The new RT300-S Pulse Oximeter will allow individuals to monitor their
pulse rate and spot oxygen saturation while using the RT300-S. The pulse
oximetry data is also saved into the RT300-S internet database. This
database allows both patients and clinicians are able to monitor therapy
progress no matter where the patient lives.

 "The RT300-S Pulse Oximeter interface will allow clinicians to optimize the
physical benefits of exercise in individual patients by applying heart rate
range response in producing optimal cardiovascular conditioning, both when
the patient is in the clinic and when at home," says John McDonald, MD, PhD,
founder of Restorative Therapies, Inc., lead Neurologist to the Late
Christopher Reeve, and director of the International Center for Spinal Cord
Injury at the Kennedy Krieger Institute in Baltimore. "This will add to the
outcome data that is already being collected from so many RT300-S patients -
making it an even more valuable research tool," McDonald concludes.

 "The BlueTooth Pulse Oximeter will help clinicians see how hard patients
are working and progressing in their electrical stimulation therapy," says
Andrew Barriskill, CEO of Restorative Therapies. "This is the latest result
of our strong commitment to ongoing development of the RT300-S system as we
work to deliver improved outcomes for our patients."

 Restorative Therapies , is a privately-held company headquartered in
Baltimore, Md., whose mission is to help people with neurological impairment
achieve their full recovery potential. Restorative Therapies is one of the
first companies to target activity-based therapy and FES as a treatment for
immobility associated with paralysis such as stroke, multiple sclerosis and
spinal cord injury.

For further information please call 800 609-9166.

 About Dr. John McDonald

John W. McDonald, MD, PhD, directs the International Center for Spinal Cord
Injury at Kennedy Krieger Institute. From 1998-2004, prior to joining
Kennedy Krieger, he founded and served as director of the Spinal Cord Injury
Program at Washington University School of Medicine in St. Louis. His
clinical and scientific work has been recognized by many organizations,
including the National Institutes of Health, International Neurotrauma
Society and American Academy of Neurology.

Dr William Boothe
Received on Fri Aug 24 2007 - 10:44:09 EDT

This archive was generated by hypermail 2.2.0 : Fri Aug 24 2007 - 10:44:23 EDT